Mar
5

Lower fee schedules, increase costs?

Dr Rebecca Yang discussed the correlation of fee schedules and associated physician billing activity.

Key takeaways

  • There’s somewhat of a correlation between low office visit reimbursement rates and higher incidence of physician dispensing.
  • evidence from CA indicates that when th FS whas reduced, doctors coding practices did too – more office visits were coded as level 4 and level 5, while the frequency of lower level visits decreased proportionally
  • when the fee schedule was subsequently increased, the trend to more upcoding moderated – then resumed when the fee schedule was frozen again.
  • this experience was essentially replicated in Louisiana
  • in Florida, a change to the fee schedule for facility-based lumbar MRIs essentially increased reimbursement for “unscheduled” MRIs when compared to “scheduled” MRIs.  Perhaps you, dear reader, will not be shocked to learn that “unscheduled” MRIs went from about 1/3 of all lumbar MRIs to over 2/3 over the next few years.

What does this mean for you?

Blunt instruments – such as the physician fee schedules in place in 42 states – CAN BE opportunities for bad actors to game the system, while hurting the good folks.  

Not to say they should be abandoned, but rather it is necessary to think about what will happen if you change fees (or other care-based reimbursement rules) – not what you hope will happen.


Mar
5

ProPublica’s demolition of workers’ comp

Yesterday ProPublica published the first in what is apparently a series of articles on the workers comp systems around the country. This first effort focused on ‘reforms’ and generally indicated these are driven by big employers seeking to cut workers benefits and medical costs.

There is much coverage of grievous injuries, lost limbs, different compensation systems in different states and the role of big business in writing reforms.

I would suggest that writing about reforms, without discussing what’s driving the medical care reforms, is an oversight. And there was precious little discussion of cost drivers, but a lot of discussion about cost control methods, including a tortured passage attempting to describe California’s utilization review process, and the issues inherent therein.  Unfortunately, the coverage of this issue focused on the denials of care, not on the reasons therefore, the process that is used, and why some requests should be denied (more on that in a later post).

Re California, I asked friend and colleague Alex Swedlow for his thoughts on how ProPublica characterized cwci’s research; here’s his perspective…

 The article would benefit from a full discussion on how much and what type of care is approved and denied.  It’s true our study showed that about 91% of the disputed denied treatments are upheld by Independent Medical Review.  What is missing from the article is that denied disputes are only 6% of all treatment reqests and that the California worker’s comp system approves 95% of all treatment.  And the 5% that is ultimatly denied is another story.

The dramatic increase in utilization review in California has been driven largely by the plaintiffs bar, which has been using the IMR process to extend disability. One has to wonder why they have been doing this. In addition IMR increases are driven by by the overuse of drugs, the changes in medical practice patterns since the treating physician presumption was overturned, and the desire on the part of many to address the overtreatment that is rampant in Worker’s Compensation.

Moreover, there was no attempt to explain why employers are seeking to direct injured workers to specific providers or panels of providers. This was presented as a problem for injured workers, when that is inmost instances absolutely not the case.

In fact, the care direction by employers was treated as somehow harming injured workers.

I was excited when I heard propublica I was going to be taking this topic on. I have been impressed by propublica’s work on many fronts. There is much about Worker’s Compensation that needs improvement. Unfortunately, my take on this article is that it is quite one sided, and does not address many of the significant issues that are leading to harm for injured workers, employers and taxpayers. As an introduction to the topic, it is seriously flawed.

While there may be other articles coming in future weeks and months, the expectation that has been set by this article is that the system is somehow tilted in the employers favor. I can assure you that in most states, this is far from reality.

I’d suggest that the story is far from complete. It ignores the rampant profiteering that is the primary driver of the reforms described in generally negative terms, fails to point out the complicity of the claimants bar in extending disability, and completely misses the damage done by profiteering physicians over-prescribing opioids and benzodiazepines and failing to work closely with payers and employers.

Data point- the back surgery scandal in California led to many unnecessary back surgeries, much pain for claimants, and tens of millions in excess costs for employers and taxpayers.

There is no question big business is behind much of these reforms just as there is also no doubt state medical societies are overwhelmingly to blame for rampant abuse of the system in states such as Florida and Maryland.

Data point- the medical society and a drug dispensing firm used the same lobbyist who successfully kept doc dispensing operating in MD thereby increasing costs and extending disabilty.

Finally the story fails to address a critical point – namely the nature of the workforce, employment, injuries and the health care system has fundamentally changed in the last 100 years.

Of course it doesn’t work now. Women are a majority of workers, employment in services long ago overtook manufacturing and industry, Medicare exists, health care systems have radically changed, and the working population is much older fatter and less fit.

It would have been quite helpful to discuss states where things are working well. Washington is one and Ohio has made great strides as well.

What does this mean for you?

If asked by a non-work-comp person about the article and subsequent pieces, you may want to suggest that reality is somewhat different from the world portrayed by ProPublica.


Mar
5

The latest data on physician dispensing from WCRI

Wcri’s experts summarized their latest research in doc dispensing in the second presentation.

A couple quick takeaways.

First, the efforts to control the price of the repackaged drugs dispensed by physicians has failed as the dispensers have effectively circumvented the rules or statute by creating “new” drugs that are remarkably similar to current medications.

this is particularly problematic in IL and CA.

Second, physicians in Florida were apparently prescribing and dispensing opioids more often than necessary as they stopped prescribing these meds when they could no longer profit from dispensing fees.

Pharmacy costs in CA are growing rapidly however the pain management guidelines seem to have led to a flattening in the growth of the more potent opioids.

CWCI exec dir Alex Swedlow provided his usual excellent debunking of the false claims made by doc dispensing advocates, noting costs are higher and disability duration longer.

The net – doc dispensing research overwhelmingly indicates the practice adds no value and benefits no one but the profiteering docs and their enablers.

 

 


Mar
5

Live blogging from WCRI

In lovely Boston this week for the annual WCRI meeting, a day and a half stuffed with Research findings data and interpretation thereof.

Warning- due to some laptop issues I’ll be posting from my iPhone, and you will undoubtedly see many more typos than usual. A prize to the reader who correctly totals all the typos over the next two days.

The conference begins with the usual WCRI disclaimer that the organization presents research results and does not take policy positions. I’m happy to infer what the results mean and what we should do about the findings.

The lead off session addressed the impact of ppaca on work comp, specifically cost shifting from group to work comp.

Olesya Fomenko Ph.D did the research on the topic with a focus on ACOs and their impact on case shifting from group to comp. Much of the discussion revolved around capitated vs fee for service reimbursement and the financial motivations of the treating provider. In a capitated system, the doc gets paid the same amount for all non-occ care, but makes more for treating occupational conditions as they are not covered under he capitation arrangement.

The key finding is the “growing use of capitation is likely to increase the number of soft tissue injuries seeking payment under WC.”  Obviously this is going to be more common in states where capitated plans are more common.  The research indicates a potential increase in soft tissue claims in the 12 or so states with a quarter or more of workers covered by capitated plans – CA NY PA MI MA etc.

If capitation increases, there may well be more states with characteristics indicating a higher propensity to shift cases from group to comp. Capitation has declined over the last decade, but the growth of acos is likely reversing this trend.

Whats not visible in the data is the question “were soft tissue claims under reported previously, and now that there are stronger financial incentives to correctly categorize claims, they are now correctly categorized?”


Mar
3

Pre-WCRI catch up…

With WCRI’s annual confab coming up Thursday am, meetings in Boston tomorrow, and lots going on already this week, here’s a quick summary of goings on from all over the health care world.

Kudos to Liberty Mutual’s (and fellow Syracuse University grad) Tammy Camillone; Tammy was just promoted to run Liberty’s bill review operation.  With the pending transition from Coventry’s 4.0 to Strataware, this is a big job – but one well within Tammy’s capabilities.

Healthplan membership climbed by 5.6 million members from Q3 2013 to Q3 2014. That’s not surprising; what is surprising is the big gains in ASO (administrative services only, or self-insured health plans for larger employers) business for Kaiser and Anthem.  While most growth was in the individual lines, the jump in employer plans indicates things are looking good for health plans across a broad spectrum of products. 

A study just published in JAMA indicates the risk of overdose from prescribed opioids may be significantly greater if the opioids are long-acting (e.g. OxyContin) vs short-acting.

To our knowledge, the findings of the present study provide the first evidence that the risk of unintentional overdose injury is related to the prescribed opioid’s duration of action. If replicated in other cohorts, our findings suggest that clinicians weighing the benefits and risks of initiating different opioid regimens should consider not only the daily dose prescribed but also the duration of opioid action, favoring short-acting agents whenever possible, especially during the first 2 weeks of therapy.

Thanks to Steven Feinberg MD for the tipoff.

Finally, there are good people in the world, and there are people who are not.

Goings-on in Maryland work comp highlights this all too well.  The physician dispensing advocates, their pawns at the Maryland medical societies, and their hired hitmen are all on the wrong side of right.

In pursuit of the almighty dollar, these slimeballs are quite willing to say anything, do anything, lie about anyone, distort any facts and compromise whatever morals they may once have had just so they can keep feeding at the trough.

A trough filled with dollars hard-earned by taxpayers and employers.


Mar
2

What Maryland SHOULD be studying

Three weeks ago a group of stakeholders in Maryland decided physician dispensing wasn’t that bad [scroll down in link].

These stakeholders agreed to not do anything legislatively to address doc dispensing for another two years because their own analysis had indicated physician dispensing in MD was not changing.  Now, a lobbyist for physician dispensing “technology” firm Automated Healthcare Solutions has penned an opinion piece that can only be described as a hit job on WCRI, a highly respected research organization.

There are two related problems here.

  • It’s obvious the doc dispensers’ strategy is to try to discredit WCRI – no other reason to publish an editorial in a paper in a state that you’ve already won.
  • The stakeholders that signed the letter agreeing to forgo any legislation ignored research from Johns Hopkins University (located in Maryland) proving physician dispensing is associated with much worse patient outcomes.

I won’t dignify the lobbyist’s moronic prattling with a point-by-point rebuttal; WCRI already has in the measured, professional, and very precise way that is the hallmark of academic research. Suffice it to say that the lobbyist’s own writing shows he is even less knowledgeable about statistics, research standards, and data analytics than our Newfies are.

This guy calling out WCRI on statistical analysis is akin to me telling Blake Shelton he doesn’t know the music business.

Next, in a letter citing the Maryland Workers’ Compensation Commission, the stakeholders asserted “contrary to previous trends reported by the Workers’ Compensation Research Institute, Maryland claimants received a smaller proportion of prescription drugs dispensed directly from their physicians, as compared with prescriptions dispensed from pharmacies.”  After much review, my conclusion is this – there are differences in the methodologies used by the MWCC and WCRI – but those differences do NOT mean WCRI’s work is wrong.

First, the data collection process the stakeholders used to come up with their conclusion is not as rigorous as it could – and likely should – have been. For example, they asked multiple sources for data on physician dispensing, but failed to provide tight criteria or definitions for these sources to categorize the data. As a result, the findings are questionable because the sources may well have:

  • used different criteria to identify “physician dispensers”
  • used different definitions of “repackaged” drugs
  • differing ability to identify what entity dispensed a drug
  • differing ability to differentiate between physician-owned “pharmacies” and retail pharmacies
  • different definitions of “generic” and “branded” drugs

Second, the MWCC analysis used an entirely different methodology than WCRI, a methodology that, among other factors, included different time periods and a different set of claims.  It is NOT surprising that different data sets, different methodologies, different time lines yield different results.

On its own initiative, WCRI used the stakeholders’ methodology in an attempt to understand the discrepancy, with the following result:

When we replicate the data and methods used by the Commission on the data used in our Maryland draft study, we get 16.7 percent where the Commission reported that 15.7 percent of prescriptions were dispensed at physicians’ offices. Hence, when we use similar methods on different data sets, we get similar results.

Ignored in the lobbyist’s “editorial”, and by the stakeholders as well, is this:

In the last published WCRI study on this topic, Maryland was compared to 20 other larger than average states. We found that physician dispensing in Maryland was more frequent than in 17 of these 20 states—twice as common as in the median state, [emphasis added] and four times more frequent than in the neighboring state of Virginia. 

Rather than get into a “mine’s better than your’s” conversation, here’s what we know.

There’s no question Maryland has a very large physician dispensing problem – one that all the research indicates is likely driving worse outcomes for patients and higher costs for employers and taxpayers.  The really troubling thing here is the stakeholders know, or should have known outcomes may be significantly and adversely affected by doc-dispensed drugs, yet went along with the deal.

In conversations with stakeholders, I asked why they didn’t consider this, and got no answer.  When I pressed and asked if they were going to work with JHU’s researchers to look at outcomes, I was told they “may have to think about that.”

Think about…what?

I don’t think these stakeholders are bad people or ill-intentioned; they do have a lot on their collective plate.

I do think they have – for their own reasons, which may make sense to them – given up the fight against physician dispensing.

In so doing, they are missing out on an opportunity to help Maryland employers, taxpayers, and injured workers.

They are also empowering the dispensers in other states.

What does this mean for you?

All the research indicates physician dispensing increases disability duration, indemnity expense and medical costs.  THAT is what Maryland should study.

Note – in the interest of full disclosure, I am (as most of you already know) president of CompPharma LLC, a consortium of workers’ compensation PBMs. It’s also important for readers to know that it matters not one iota to me financially if physician dispensing increases or decreases.

It does matter to me personally as it is flat out wrong. It is bad policy that is damaging the many to enrich a very few.


Feb
27

It’s March! well, almost…

Here’s the quick update on goings-on this week.

First, Helios has an excellent synopsis of rules, regs, and laws affecting many aspects of workers’ comp medical management here.  Get it, save it, and you’ll find it’s a great reference.

Kudos to David Williams!  His Health Business Blog has its tenth anniversary this week; he celebrates by hosting a most excellent Health Wonk Review.  Posts on hypocrisy and executive compensation at a Catholic Health Network, convoluted and mostly losing efforts to avoid the PPACA mandate, hospitals’ patient experience ratings and the profitability of fund-raising make for a quick roundup of news and views certain to keep you on top of all things health policy.

Ben Miller at WorkCompCentral reports on the recent spate of mergers in the PBM world (subscription required).  Ben discusses the non-work comp market, noting WC is affected by goings-on in the (much larger) group health, medicare/medicaid world.

Heard about several PT provider groups who are quite concerned/angry/furious re the 59 modifier issue.  Two have retained outside counsel and both are pursuing audits.

Finally, here’s a really good piece on how some efforts to motivate employees are counter-productive; Hint – it isn’t (all) about money – but it isn’t that simple either. Well worth your time.


Feb
26

The work comp PBM industry’s evolution continues

The news that Catamaran has acquired PBM, bill review, and network company Healthcare Solutions is yet more evidence that the workers’ comp services market is mature and evolving.  Nowhere is this more evident than the WC PBM industry where there are now six major PBMs, down from ten just five years ago.

This is partly due to the change in definition of “major”; as industries consolidate the size of the companies increases as scale and buying power become critical to success.

As a colleague pointed out, this transaction doesn’t consolidate the industry per se…

Here are the key data points…

  • HCS’ purchase price is $405 million
  • at EBITDA of $35 million, the multiple is a very healthy 11.6x
  • the deal is expected to close in the second quarter
  • Catamaran’s revenues for 2014 were over $21 billion

The transaction transforms Catamaran, the fourth largest PBM serving the health, Medicare and Medicaid industries from a back office and network supplier to the workers’ comp PBM industry to a direct vendor. Things could get complicated, as WC PBMs Carlisle and myMatrixx use Catamaran’s back office and network services.

Sources indicate HCS’ management and staff will remain in place; good move as CEO Joe Boures has a very strong team that has delivered solid sales improvements, a robust and effective clinical program, and strong customer relationships.  As Catamaran doesn’t have these capabilities in-house, and HCS is growing in a mature industry, I’d expect minimal changes.

What does this mean?

Several takeaways.

  • multiples remain very strong – good news for anyone considering selling their company.  Considering it looks like this wasn’t an auction but rather a direct sale, this bodes well for anyone considering a transaction.
  • strong management drives value; after several years of spotty performance, a revamped management team has created a lot of value for HCS’ owners (full disclosure – I have a tiny equity stake left over from a previous role on HCS predecessor Cypress Care’s advisory board)
  • very happy for the Datelle family (founders of Cypress Care); Hank, Marc, and Lisa are all friends and it’s good to see them do well – again.

more to come…


Feb
24

King V Burwell and the Supremes’ view of “standing”

“Federal courts are courts of limited jurisdiction,” the acting United States solicitor general explained to the Supreme Court in a 1990 argument. “The presumption is that they are without jurisdiction, and the plaintiff must affirmatively prove that he has standing to invoke the power of the court.”

That’s a quote from Supreme Court Chief Justice John Roberts – given that Roberts and his fellow Justices will be ruling on the suit that seeks to disallow subsidies for policies obtained via the Federal health exchange, it has special meaning.

The suit, funded by the Koch-backed Competitive Enterprise Institute, is ostensibly being brought by four plaintiffs who, in theory, have to prove they were harmed in order to have “standing”.  In a nutshell, “standing” means that if you aren’t harmed by an action, then you can’t complain about it.  I may not like the speed limit in Hawaii, but since I never go there I have no standing to sue.

As several news outlets have reported, three plaintiffs don’t have much to complain about; this from the Wall Street Journal:

Legal experts say the fact that Mr. King could avoid paying the penalty for lacking insurance by enrolling in VA coverage undermines his legal right to bring the case, known as “standing.” The wife of a second plaintiff has described her husband on social media as being a Vietnam veteran. The government previously questioned the standing of a third plaintiff on the grounds that her income may exempt her from paying the penalty for lacking insurance, but a lower court didn’t address the issue.

The fourth plaintiff, Brenda Levy, is Medicare-eligible in June of this year – about the time the Court would rule on the case.  As I am NOT a legal scholar or lawyer, and don’t even watch legal shows on TV, I’m not qualified to say whether Medicare eligibility changes “standing” (Medicare recipients can’t be forced to carry insurance under PPACA as they are covered by Medicare).  If it doesn’t, then the case will go forward as even one plaintiff with standing is enough.

That said, this Court seems – to my uneducated eye – to use “standing” to avoid ruling on contentious issues.

What does this mean for you?

Hard to say, as handicapping this Court is a fool’s game.


Feb
20

Friday update

There’s a lot going on these days; several major private equity transactions in the works with one on the cusp of closure (and no I can’t name the companies),

ARAWC is a new group led by Sedgwick’s Chris Mandel in an effort to expand employers’ ability to opt out of workers’ comp.  Currently Texas and Oklahoma are the only states that allow employers to not carry workers’ comp; there is a bill in Tennessee that would make the Volunteer State the third.

Smart move on the part of the giant TPA; expands the brand, positions S as a player in the new niche, and generates conversations with employers that otherwise wouldn’t happen.  Sedgwick gets marketing.

For those interested in more details on correct coding, the folks at Equian have added a sequel to their popular Correct Coding Initiative video.  With all the excitement about the 59 modifier out there, it’s well worth the 4 minutes.

In the “I CANNOT WAIT TILL I CAN STOP TALKING ABOUT THIS” category, a college in Baltimore has set up an educational program to train doctors on physician dispensing.  This after Maryland’s recent decision to not do anything about physician dispensing because, according to data collected by DWC, it is not a problem.

This just in; physician dispensing advocates and their supporters spent just over a million dollars lobbying last year in Pennsylvania.  That’s the total from examining reporting for 2014 for the various dispensing companies, medical societies and fellow travelers who were focusing on doc dispensing.

Nice of them to use employers’ and taxpayers’ dollars to try to suck even more dollars out of those very thin wallets.  Even nicer that they lost.

Enjoy the weekend…